Professor
Mark Dawson
FAA FAHMS
Mark Dawson is a clinician-scientist whose research focuses on studying the biological mechanisms by which epigenetic regulators facilitate the induction, maintenance and progression of cancer. His innovative research program has provided several paradigm shifting discoveries into epigenetic mechanisms of cancer stem cell maintenance, resistance to anti-cancer therapies and regulation of anti-cancer immune surveillance. His research has directly contributed to the development of several first-in-class epigenetic therapies, including those that have been studied in more than 30 clinical trials across at least 20 countries. His leading international reputation is evidenced by his publications, grant funding, invitations to speak and the receipt of prestigious prizes and awards for his research.
Fields of research
31 BIOLOGICAL SCIENCES-
3105
GENETICS
- 310504 Epigenetics (incl. Genome Methylation and Epigenomics)
-
3109
ZOOLOGY
- 310902 Animal Cell and Molecular Biology
-
3211
ONCOLOGY AND CARCINOGENESIS
- 321101 Cancer Cell Biology
- 321106 Haematological Tumours
For full list of research codes, please visit the ARC Website .
Expertise type
- Transcriptional regulation
- Cancer Biology
- Medical Sciences
- Cancer Medicine
- Epigenetics
- Cell Biology
- Haematology
- Molecular Biology
Please contact fellowship@science.org.au to request any updates to the data.